Optimisticc
Opportunity To Investigate the Microbiome’s Impact on Science and Treatment In Colorectal Cancer
A Cancer Grand Challenges project funded by Cancer Research UK.
About the Program
We are an international team working together to understand the colorectal cancer microbiome: what it is, how it is associated with cancer, and what treatments will affect the microbiome to promote health.
Our objectives are to:
- Map the colorectal cancer microbiome
- Develop microbiome-targeted therapies for colorectal cancer
- Share and disseminate our findings
What’s New
Allen-Vercoe group publishes book chapter on Fusobacteria.
Graduate students Avery Robinson and Jacob Wilde contributed to a book chapter with Emma Allen-Vercoe that covers man...
Avery Robinson and Greg Higgins awarded Canada Graduate Scholarships
Pop some champagne and toast Avery Robinson and Greg Higgins of the Allen-Vercoe lab! Avery won a Canada Graduate Sch...
45 is the New 50
On October 27, 2020, the U.S. Preventive Services Task Force issued a recommendation that colorectal cancer screening...
Dr. Kimmie Ng on the death of “Black Panther” actor Chadwick Boseman and Young-Onset CRC
As a result of the tragic and untimely death of actor Chadwick Boseman from...
IL-22 Pathway Identified as a New Target in Colon Cancers with Mutant KRAS
Work from Dr. Fiona Powrie’s group at University of Oxford has identified an interaction between the receptor for the...
Co-Investigator and Advocate Dr. Laura Porter shares notes from the ASCO 2020 Virtual Meeting
I attended the virtual annual meeting of the American Society of Clinical Oncology (ASCO) May 29-31, 2020. I...
Our Sponsor
OPTIMISTICC is a Cancer Grand Challenges team funded by Cancer Research UK.
Our Partners
